Reshma Mahtani
- Oncology top 10%
- Cancer Treatment and Pharmacology 27
- HER2/EGFR in Cancer Research 26
- Neutropenia and Cancer Infections 7
- PARP inhibition in cancer therapy 7
- Cancer Research top 10%
- Breast Cancer Treatment Studies 23
- Cancer Genomics and Diagnostics 7
-
- Advanced Breast Cancer Therapies 37
-
- BRCA gene mutations in cancer 12
- Co-authors
- Charles L. VogelMohammad JahanzebJohn S. MacdonaldMuaiad KittanehAlberto J. MonteroMark D. PegramLee S. SchwartzbergElyse E. Lower
- Journals
- Journal of Clinical Oncology (15 papers)Cancer Research (8 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Reshma Mahtani
73 papers receiving 620 citations
Peers
Comparison fields: 5 of 69
- Oncology 438
- Cancer Research 194
- Pulmonary and Respiratory Medicine 229
- Radiology, Nuclear Medicine and Imaging 110
- Genetics 39
Countries citing papers authored by Reshma Mahtani
This map shows the geographic impact of Reshma Mahtani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshma Mahtani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshma Mahtani more than expected).
Fields of papers citing papers by Reshma Mahtani
This network shows the impact of papers produced by Reshma Mahtani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshma Mahtani. The network helps show where Reshma Mahtani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Reshma Mahtani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 3 | |
| 11 | 2020 | 12 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2019 | 2 | |
| 16 | 2019 | 17 | |
| 17 | 2018 | 9 | |
| 18 | 2014 | 13 | |
| 19 | 2010 | 13 | |
| 20 | 2009 | 20 |
About Reshma Mahtani
Reshma Mahtani is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 80 papers that have together received 630 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (37 papers), Cancer Treatment and Pharmacology (27 papers), HER2/EGFR in Cancer Research (26 papers), Breast Cancer Treatment Studies (23 papers), BRCA gene mutations in cancer (12 papers), Neutropenia and Cancer Infections (7 papers), Cancer Genomics and Diagnostics (7 papers) and PARP inhibition in cancer therapy (7 papers). The work is most often cited by research in Oncology (438 citations), Cancer Research (194 citations) and Pulmonary and Respiratory Medicine (229 citations). Reshma Mahtani has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Charles L. Vogel, Mohammad Jahanzeb, John S. Macdonald, Muaiad Kittaneh, Alberto J. Montero, Mark D. Pegram, Lee S. Schwartzberg, Elyse E. Lower, Nadia Harbeck and Eugene R. Ahn. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.